DKK3 and kidney disorder: The size of each subgroup (N = 100 in total, 20 subjects each) is low, nevertheless, to the best of our knowledge, this is the first study that comprehensively addressed the value of serum and urine Dkk3 as novel biomarker in patients within the whole spectrum of renal disease.